Millennium Management’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Millennium Management’s Portfolio AZR Stock Details AZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-63	Closed	-$53K	–	7013
2022 Q2	$53K	Buy	+63	New	+$57K	﹤0.01%	6179
2022 Q1	–	Sell	-33	Closed	-$56K	–	6833
2021 Q4	$56K	Buy	33 +6	+22%	+$11.8K	﹤0.01%	6446
2021 Q3	$73K	Buy	+27	New	+$56.5K	﹤0.01%	6513
2019 Q2	–	Sell	-94	Closed	-$201K	–	3999
2019 Q1	$201K	Buy	+94	New	+$280K	﹤0.01%	3733
2018 Q4	–	Sell	-27	Closed	-$50K	–	3702
2018 Q3	$50K	Buy	+27	New	+$56K	﹤0.01%	3808

Other funds holding AZR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management's AZR Position: Q3 2022 in Review

Millennium Management sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q3 2022, closing a stake of 63 shares — an estimated $53K sold.

Millennium Management first reported a position in AZR in Q3 2018 and held it in 5 quarters. The position peaked at $201K in Q1 2019. 26 funds tracked by Wall St. Rank hold AZR as of Q3 2022.

Millennium Management reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 63 Azora Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $53K.
Millennium Management first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Millennium Management's Azora Therapeutics, Inc. Common Stock position peaked at $201K in Q1 2019.
26 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.